Overview / Abstract: |
Target Audience Program Overview Learning Objectives Assess the clinical benefits and disadvantages associated with dopamine-modulating antipsychotic medications approved for the management of schizophrenia |
Expiration |
Apr 13, 2024 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Christoph U. Correll, MD |
Sponsors / Supporters / Grant Providers |
Med Learning Group, Ultimate Medical Academy/Complete Conference Management (CCM), Sunovion, Otsuka |
Keywords / Search Terms |
Relias LLC Primary Care, Schizophrenia Free CE CME |